Key result
SSRIs are the first-line treatment for depression in patients with cardiovascular disease and can be used safely with appropriate dosing and ECG monitoring.
Why the study?
Depressive disorder is a significant risk factor for the development and progression of cardiovascular diseases, necessitating early diagnosis and adequate treatment.
Does antidepressant therapy safely and effectively treat depression in patients with cardiovascular disease?
Does antidepressant therapy safely and effectively treat depression in patients with cardiovascular disease?
SSRIs are the preferred safe and effective treatment for depression in patients with cardiovascular disease, though careful monitoring of ECG and blood pressure is necessary.
Supports SSRI use for depression in CVD patients; leaves open confirmation from randomized trials.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Eva Kitzlerová (2021) conducted a review in Depression in patients with cardiovascular disease. Antidepressants (SSRIs, SNRIs, and novel agents) was evaluated. SSRIs are the first-line treatment for depression in patients with cardiovascular disease and can be used safely with appropriate dosing and ECG monitoring.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: